- Investing Ideas
- U.S. Pharmaceuticals & Biotech High Growth Stocks
U.S. Pharmaceuticals & Biotech High Growth Stocks
Results
5
High Growth Stocks
5 companies
Zevra Therapeutics
Market Cap: US$681.7m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.34
7D
7.8%
1Y
-3.6%
Kiniksa Pharmaceuticals International
Market Cap: US$6.0b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$77.80
7D
2.4%
1Y
137.3%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$26.23
7D
0.8%
1Y
78.0%
BeOne Medicines
Market Cap: US$40.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$359.27
7D
11.2%
1Y
24.7%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.11
7D
5.5%
1Y
28.6%